¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"glycine cleavage system"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
¿µ¹® hepatic portal system ÇÑ±Û °£¹®¸Æ°è
¼³¸í   
  À§, ÀÛÀºÃ¢ÀÚÀ̳ª Å«Ã¢ÀÚ¿¡¼­ ¿µ¾çºÐÀ» Èí¼öÇϱâ À§ÇÑ ¸ð¼¼Ç÷°üÁ¶Á÷Àº ¸ðµÎ °£À¸·Î ¿¬°áµÈ´Ù. Áï ¼ÒÈ­±â¿¡ Èí¼öÇÑ ¿µ¾çºÐÀÌ °¡µæÇÑ ÇǴ ¸ðµÎ °£À¸·Î ¿¬°áµÇ´Âµ¥ À̰ÍÀ» ¹®¸Æ°è¶ó°í ÇÑ´Ù.
¿µ¹® system ÇÑ±Û °è, °èÅë
¼³¸í   
  ÀÎü¸¦ ±¸¼ºÇϴ °è´Â ´ÙÀ½°ú °°ÀÌ ±¸ºÐµÈ´Ù.
  
  1) ½ÉÀåÇ÷°ü°èÅë(cardiovascular system)
  
  2) È£Èí±â°è(respiratory system)
  
  3) ¼ÒÈ­±â°è(digeshive system)
  
  4) ºñ´¢±â°è(urinary system)
  
  5) »ý½Ä±â°è(genital system)
  
  6) Ç÷¾×°è(hematologic system)
  
  7) ³»ºÐºñ°è(endocrine system)
  
  8) ½Å°æ°è(nervous system)
  
  9) °ñ°Ý°è(skeletal system)
  
  10) ±ÙÀ°°è(muscular system)
  
  11) ÇǺΰè(integumentary system).
¿µ¹® sympathetic nervous system ÇÑ±Û ±³°¨½Å°æ°è
¼³¸í   
  ÀÚÀ²½Å°æ°èÀÇ ÀÏÁ¾À¸·Î ³»Àå±â´ÉÀ» ÁַΠÇ×Áø½ÃÄѠȰµ¿À» Áõ°¡½Ã۴ ±â´ÉÀ» °¡Áø´Ù. ÀÚÀ²½Å°æ°èÀÇ ´Ù¸¥ °è¿­ÀΠºÎ±³°¨½Å°æ°è´Â ¹Ý´ë·Î ³»Àå±â´ÉÀ» ¾ïÁ¦½ÃÄÑ ¿¡³ÊÁö¸¦ ºñÃàÇϴ ±â´ÉÀ» °¡Áø´Ù. ÀÚÀ²½Å°æ°èÀÇ ÇØºÎÇÐÀû Æ¯¼ºÀº ½Å°æÀÌ ÁßÃ߽Űæ°è¿¡¼­ ³ª¿Í ¸ñÇ¥Àå±â¿¡ µµ´ÞÇϱâ Àü¿¡ ÇѹøÀÇ ½Ã³À½º(synapse)¸¦ ÀÌ·é´Ù´Â Á¡À̸ç, µû¶ó¼­ ÀÚÀ²½Å°æ°è´Â µÎ °³ÀÇ ½Å°æ(½Ã³À½º¸¦ ÀÌ·ç±â ÀüÀÇ ÀýÀü½Å°æ°ú ÀÌ·é ÈÄÀÇ ÀýÈĽŰæ)À¸·Î ±¸¼ºµÈ´Ù. ÀÚÀ²½Å°æ°èÁß ±³°¨½Å°æ°è´Â ÁßÃ߽Űæ°è Áï Ã´¼ö ºÎ±ÙÀÇ ±³°¨½Å°æÀý(sympathetic ganglion)¿¡¼­ ½Ã³À½º°¡ ÀϾ°í, ºÎ±³°¨ ½Å°æ°è´Â ÁßÃ߽Űæ°è¿¡¼­ ¸Ö¸® ¶³¾îÁø ¸ñÇ¥ Àå±âºÎ±ÙÀÇ ½Å°æÀý(ganglion)¿¡¼­ ½Ã³À½º°¡ ÀϾ´Â Á¡ÀÌ ´Ù¸£´Ù.
¿µ¹® musculoskeletal System ÇÑ±Û ±Ù°ñ°Ý°è
¼³¸í   
  ±ÙÀ°°ú À̵頱ÙÀ°ÀÌ ºÙ¾î¼­ °°À̠Ȱµ¿À» ¼öÇàÇϴ °ñ°Ý(»À¸¦ ÅëÅо»ÇÔ)À» ÇÔ²² ºÎ¸£´Â ¸». µû¶ó¼­ ¿©±âÀÇ ±ÙÀ°Àº ¸ðµÎ °¡·Î¹«´Ì±Ù¿¡ ¼ÓÇϸç, ¼öÀÇÀûÀ¸·Î ¿òÁ÷ÀÏ ¼ö ÀÖ´Ù.
¿µ¹® muscular system ÇÑ±Û ±ÙÀ°°èÅë
¼³¸í   
  ±ÙÀ°¿¡ ÀÇÇØ ÀÌ·ç¾îÁø ÇϳªÀÇ °èÅëÀ» ÀÓÀÇÀûÀ¸·Î ³ª´©¾î ºÎ¸¥ ¸».
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • glycine
    ±Û¶óÀ̽Å
  • glycine amidinotransferase
    ±Û¶óÀ̽žƹ̵ò±âÀüÀÌÈ¿¼Ò
  • asymmetric cleavage
    ºñ´ëĪºÐÇÒ
  • bilateral cleavage
    ¾çÂʺÐÇÒ
  • cleavage
    1. ºÐÇÒ, ³­ÇÒ 2. Àý´Ü
  • cleavage line
    ºÐÇÒ¼±
  • cleavage nucleus
    ºÐÇÒÇÙ
  • cleavage plane
    ºÐÇÒ¸é
  • cleavage view
    Æ´»õ¿µ»ó
  • determinate cleavage
    È®Á¤ºÐÇÒ
  • discoidal cleavage
    ¿ø¹ÝºÐÇÒ
  • equal cleavage
    ±ÕµîºÐÇÒ
  • holoblastic cleavage
    ¿ÂºÐÇÒ, ÀüüºÐÇÒ
  • immunoglobulin cleavage
    ¸é¿ª±Û·ÎºÒ¸°ºÐÇÒ
  • indeterminant cleavage
    ¹ÌÁ¤ºÐÇÒ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cleavage
    ºÐÇÒ, ³­ÇÒ, Àý´Ü
  • glycine
    ±Û¸®½Å
  • system analysis
    °èÅëºÐ¼®
  • system
    1.°è, °èÅë, ü°è, 2.ÀåÄ¡, 3.Á¦µµ,
  • Bethesta system
    º£Å×½ºÅ¸ºÐ·ù(¹ý)
  • biliary system
    ´ãµµ°è, ¾µ°³°èÅë
  • blood group system
    Ç÷¾×Çü±º
  • central nervous system
    ÁßÃ߽Űæ°è, ÁßÃ߽Űæ°èÅë
  • information system
    Á¤º¸Ã¼°è
  • lymphatic system
    ¸²ÇÁ°èÅë
  • nervous system
    ½Å°æ°è, ½Å°æ°èÅë
  • open system
    1. °³¹æÁ¦, 2. °³¹æÇüº´¿ø
  • peripheral nervous system
    ¸»ÃʽŰæ°è, ¸»ÃʽŰæ°èÅë
  • registration system
    ½Å°íÁ¦µµ, µî·ÏÁ¦µµ
  • reproductive system
    »ý½Ä°èÅë
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • glycine
    ±Û¸®½Å
  • asymmetric cleavage
    ºñ´ëĪºÐÇÒ
  • bilateral cleavage
    ¾çÂʺÐÇÒ
  • cleavage
    ºÐÇÒ, ³­ÇÒ, Àý´Ü
  • cleavage line
    ºÐÇÒ¼±
  • cleavage nucleus
    ºÐÇÒÇÙ
  • cleavage plane
    ºÐÇÒ¸é
  • cleavage view
    Æ´»õÃÔ¿µ»ó
  • determinant cleavage
    È®Á¤ºÐÇÒ
  • discoidal cleavage
    ¿ø¹ÝºÐÇÒ
  • equal cleavage
    ±ÕµîºÐÇÒ
  • holoblastic cleavage
    ¿ÂºÐÇÒ, ÀüüºÐÇÒ
  • immunoglobulin cleavage
    ¸é¿ª±Û·ÎºÒ¸°ºÐÇÒ
  • indeterminant cleavage
    ¹ÌÁ¤ºÐÇÒ
  • meridional cleavage
    ¼¼·ÎºÐÇÒ, ³¯ÁÙºÐÇÒ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • holoblastic cleavage total cleavage
    ÀüüºÐÇÒ
  • Glycine
    ±Û¸®½Å, ±Û¶óÀ̽Å
  • active glycine
    Ȱ¼º(üÀàõ)±Û¸®½Å.
  • arginine-glycine-aspartic acid
    Arginine-glycine-aspartic acid
  • glycine
    ±Û¸®½Å
  • anterior chamber cleavage syndrome
    Àü¹æ(°¢)ºÐ¸®ºÎÀüÁõÈıº
  • holoblastic cleavage
    ÀüÇÒ(îïùÜ), Àü¹è¼º ºÐÇÒ(îïÛÏàõÝÂùÜ).
  • immunoglobulin cleavage
    ¸é¿ª±Û·ÎºÒ¸°ºÐÇÒ
  • indeterminant cleavage
    ¹ÌÁ¤ºÐÇÒ
  • indeterminate cleavage
    ºÎÁ¤ºÐÇÒ(ÝÕïÒ ÝÂùÜ).
  • radial cleavage
    ºÎê»ìºÐÇÒ
  • T-tubular system =>transverse tubular system
    T-°è, °¡·Î¼Ò°ü °èÅë
  • ABH system
    ABH °è(Åë)
  • ABO blood group system
    ABOÇ÷¾×Çü°è(Åë).
  • ABO blood group=ABO system
    ABO Ç÷¾×Çü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • glycine cleavage enzyme system
  • holoblastic cleavage total cleavage
    ÀüüºÐÇÒ
  • active glycine
    Ȱ¼º(üÀàõ)±Û¸®½Å.
  • arginine-glycine-aspartic acid
    Arginine-glycine-aspartic acid
  • glycine
    ±Û¸®½Å
  • tellurite glycine medium
    ÅÚ·ç¶óÀÌÆ®±Û¶óÀ̽ŹèÁö
  • transverse tubular system =T system
    ÀÌ ·Î¼Ò°ü°èÅë, T°è(¡­Í§), ȾÇà¼Ò°ü°è(üôú¼á³Î·Í§) ±Ù(ÐÉ)ÀÇ .
  • anterior chamber cleavage syndrome
    Àü¹æ(°¢)ºÐ¸®ºÎÀüÁõÈıº
  • asymmetric cleavage
    ºñ´ëĪºÐÇÒ
  • bilateral cleavage
    ¾çÃøºÐ¿­(¡­ÝÂæñ).
  • bilateral cleavage
    ¾çÂʺÐÇÒ
  • cleavage
    ºÐÇÒ(ÝÂùÜ), ³­ÇÒ(ÕµùÜ).
  • cleavage
    ºÐÇÒ
  • cleavage
    ºÐÇÒ, Àý´Ü
  • cleavage defect
    ºÐÇÒ°áÇÔ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Holoblastic cleavage [Total cleavage]
    ÀüüºÐÇÒ
    [¿¾ ¿ë¾î] Àü³­ÇÒ
  • Fornical system
    ³úȰ°èÅë
    [¿¾ ¿ë¾î] ³ú±Ã°è
  • Glial cell of peripheral nervous system
    ¸»ÃʾƱ³¼¼Æ÷
    [¿¾ ¿ë¾î] ¸»Ãʱ³¼¼Æ÷
  • Osteon [Harversian system]
    »À´ÜÀ§
    [¿¾ ¿ë¾î] °ñ¿ø
  • Genital system
    »ý½Ä°èÅë
    [¿¾ ¿ë¾î] »ý½Ä±â°èÅë
  • Cardiac conducting system
    ½ÉÀåÀüµµ°èÅë
    [¿¾ ¿ë¾î] ½ÉÀåÀÚ±ØÀüµµ°è
  • Conduction system of heart
    ½ÉÀåÀüµµ°èÅë
    [¿¾ ¿ë¾î] ½ÉÀåÀüµµ°è
  • CENTRAL NERVOUS SYSTEM
    ÁßÃ߽Űæ°èÅë
    [¿¾ ¿ë¾î] ÁßÃ߽Űæ°è
  • Glial cell of central nervous system
    ÁßÃ߾Ʊ³¼¼Æ÷
    [¿¾ ¿ë¾î] ÁßÃß±³¼¼Æ÷
  • Renal system
    ÄáÆÏ°èÅë
    [¿¾ ¿ë¾î] ½ÅÀå°èÅë
  • Primitive duct system
    ¿ø½Ã°ü°èÅë
    [¿¾ ¿ë¾î] ¿ø½Ã°ü°èÅë
  • Equal cleavage
    ±ÕµîºÐÇÒ
    [¿¾ ¿ë¾î] µîÀü³­ÇÒ
  • Spiral cleavage
    ³ª¼±ºÐÇÒ
    [¿¾ ¿ë¾î] ³ª¼±¼º³­ÇÒ
  • Meridional cleavage plane
    ³¯ÁÙºÐÇÒ¸é
    [¿¾ ¿ë¾î] °æ¼±³­ÇÒ¸é
  • Indeterminant cleavage
    ¹ÌÁ¤ºÐÇÒ
    [¿¾ ¿ë¾î] ºÎÁ¤³­ÇÒ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • glycine cleavage enzyme
    ±Û¶óÀ̽ŠºÐÇÒ È¿¼Ò(ÝÂùÜý£áÈ)
  • glycine-allantoin cycle
    ±Û¶óÀ̽Å-¾Ë¶õÅäÀΠȸ·Î(üÞÖØ)
  • glycine-succinate cycle
    ±Û¶óÀ̽Å-¼®½Å»ê(ß«) ȸ·Î(üÞÖØ)
  • citrate cleavage enzyme
    ½ÃÆ®¸£»êÀý´ÜÈ¿¼Ò(ï·Ó¨ý£áÈ)
  • cleavage map
    Àý´Ü Áöµµ(ï·Ó¨ò¢Óñ)
  • orthophosphate cleavage
    ¿À¸£ÅäÀλê Àý´Ü(×òß«ï·Ó¨)
  • pyrophosphate cleavage
    ÆÄÀÌ·ÎÀλê(×òß«) ºÐÇØ(ÝÂú°)
  • side chain cleavage
    °ç°¡Áö Àý´Ü(ï·Ó¨)
  • thiolytic cleavage
    °¡(Ê¥)ŸÀ̿à Àý´Ü(ï·Ó¨)
  • ABO blood group (type) system
    ABOÇ÷¾×Çü (úìäûúþ) ½Ã½ºÅÛ
  • absorption optical system
    Èí¼ö(ýåâ¥) ±¤ÇÐ(ÎÃùÊ) ½Ã½ºÅÛ
  • adiabatic system
    ´Ü¿­(Ó¨æð)½Ã½ºÅÛ
  • ATP regeneration system
    ATPÀç»ý(î¢ßæ) ½Ã½ºÅÛ
  • binding protein transport system
    °áÇÕ ´Ü¹éÁú ¼ö¼Û(Ì¿ùêÓ±ÛÜòõâÃáê) ½Ã½ºÅÛ
  • brain barrier system
    ³úÀ庮(Òàî¡Ûú) ½Ã½ºÅÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cleavage
    ºÐÇÒ, ³­ÇÒ
  • cleavage view
    Æ´»õÃÔ¿µ»ó
  • array system
    ¹è¿­ÀåÄ¡, ¹è¿­Ã¼°è
  • cardiovascular system
    ½ÉÀåÇ÷°ü°è
  • central nervous system [=CNS]
    ÁßÃ߽Űæ°è(Åë)
  • CNS [=central nervous system]
    ÁßÃ߽Űæ°è(Åë)
  • conventional film screen system
    ±âÁ¸Çʸ§Ã¼Áµ
  • digestive system
    ¼ÒÈ­±â°èÅë
  • display system
    Ç¥½ÃÀåÄ¡
  • DOS [=disk operating system]
    µð½ºÅ©¿î¿µÃ¼Á¦
  • electronically steered system
    ÀüÀÚÁ¶ÇâÀåÄ¡
  • hospital information system(HIS)
    º´¿øÁ¤º¸È­Ã¼°è
  • lymphatic system
    ¸²ÇÁ°è
  • OCS(order communication system)
    ó¹æÀü´Þü°è
  • operating system [=OS]
    ¿î¿µÃ¼°è
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
GCS general clinical services; Gianotti-Crosti syndrome; Glasgow Coma Scale; glucocorticosteroid; glutam...
GCSP glycine cleavage system protein
ISIS image selected in vivo spectroscopy; imaging science and information system; information system-imag...
HCG, hCG Human Chorionic Gonadotropin; »ç¶÷À¶¸ð¼º¼º¼±ÀÚ±ØÈ£¸£¸ó
  1. Placental Glycoprotein Hormone
&nbs...
SCC   1) Sude Chain-Cleavage Complex
  2) Squamous Cell Carcinoma
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
DCG-IV 1S,1'R,2'R,3'R)-2-(2,3-dicarboxycyclopropyl)glycine
2-MPG 2-Mercapto-Priopionyl-Glycine
DCG IV 2S,2'R,3'R)-2-(2',3'-dicarboxycyclopropyl)-glycine
L-CCGI 2S,3S,4S)-alpha-(Carboxy-cyclopropyl)glycine
CG Cholyl glycine
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • asymmetric cleavage
    ºñ´ëĪ ºÐÇÒ
  • cleavage cavity
    ºÐÇÒ °­, ³­ÇÒ °­
    Æ÷¹èÀÇ °­. ÇÒ°­.
  • cleavage plane
    ºÐÇÒ ¸é
  • cleavage site
    ºÐ¿­ ºÎÀ§
  • equal cleavage
    µîÇÒ
  • equatorial cleavage plane
    Àûµµ ºÐÇÒ¸é
  • right spiral cleavage
    ¿À¸¥ ³ª¼± ºÐÇÒ
  • unephral : µ¿ÀǾî=neptal.

    unequal cleavage

    ºÒ±Õµî ºÐÇÒ
  • ABO blood group system
    ABO Ç÷¾×Çü°è, ABO Ç÷¾×Çü °èÅë
    A, B´Â ¿ì¼º, O´Â ¿­¼ºÀ¸·Î¼­, A, B, AB, OÇüÀÌ ÀÖ´Ù.
  • ABO system
    ABO Çü, ABO °èÅë
  • achromatic system
    ¹«»ö°è
  • aerospace life support system
    ¿ìÁÖ¿ë »ý¸í À¯Áö ½Ã½ºÅÛ
  • affecting multiple system
    ´Ù¹ß¼º °èÅëÀ» ħ¹üÇÑ
  • affectional system
    Á¤µ¿ ü°è
  • afferent system
    ±¸½É ½Å°æ°è
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
glycine cleavage complex A complex of several proteins that catalyze the reversible reaction of glycine with tetrahydrofolate to produce CO2, NH3, and N5,N10-methylenetetrahydrofolate; a deficiency of this enzyme (or one of its subunits) will result in nonketotic hyperglycinaemia.
Synonym: glycine synthase.
(05 Mar 2000)
aralkyl-CoA-glycine N-acyltransferase <enzyme> Involved in conjugation of xenobiotics such as substituted benzoic acids or medium chain fatty-acyl-coas with glycine; n-terminal amino acid sequence given in first source
Registry number: EC 2.3.1.-
Synonym: aralkyltransferase, aralkyl-CoA-glycine n-glycyltransferase
(26 Jun 1999)
receptors, glycine Cell surface receptors that bind glycine with high affinity and trigger intracellular changes which influence the behaviour of cells. Glycine receptors in the central nervous system have an intrinsic chloride channel and are usually inhibitory.
(12 Dec 1998)
glycine <amino acid, physiology> The simplest amino acid. It is a common residue in proteins, especially collagen and elastin and is not optically active.
It is also a major inhibitory neurotransmitter in spinal cord and brainstem of vertebrate central nervous system.
(18 Nov 1997)
glycine acyltransferase <enzyme> An enzyme catalyzing the reversible transfer of an acyl group from acyl-CoA to glycine, producing free coenzyme A and N-acylglycine; a step in a detoxification pathway.
(05 Mar 2000)
glycine agents Substances used for their pharmacological actions on glycinergic systems. Glycinergic agents include agonists, antagonists, degradation or uptake inhibitors, depleters, precursors, and modulators of receptor function.
(12 Dec 1998)
glycine amidinotransferase <enzyme> An enzyme catalyzing the transfer of an amidine group from l-arginine to glycine, forming guanidinoacetate and l-ornithine; an important reaction in creatine synthesis; it can also act on canavanine.
Synonym: glycine transamidinase.
(05 Mar 2000)
glycine betaine <chemical> A derivative of glycine characterised by high water solubility. Can function as an osmotic agent in plant tissues.
See: biogenic amines.
(18 Nov 1997)
glycine dehydrogenase Enzymes that catalyze the conversion of glycine to glyoxylate and ammonia, using either NAD+ or ferricytochrome c.
(05 Mar 2000)
glycine hydroxymethyltransferase <enzyme> A pyridoxal phosphate enzyme that catalyses the reaction of glycine and 5,10-methylene-tetrahydrofolate to form serine. It also catalyses the reaction of glycine with acetaldehyde to form l-threonine.
Chemical name: 5,10-Methylenetetrahydrofolate:glycine hydroxymethyltransferase
Registry number: EC 2.1.2.1
(12 Dec 1998)
glycine methyltransferase <enzyme> Liver protein sediments in the 4-s region of sucrose gradients; binds to benzo(a)pyrene and to folate
Registry number: EC 2.1.1.20
Synonym: glycine n-methyltransferase, carcinogen-binding protein, 4s carcinogen-binding protein, 4-s carcinogen-binding protein, 4s polycylic aromatic hydrocarbon-binding protein, 4s pah-binding protein, pah-binding protein
(26 Jun 1999)
glycine receptor <physiology> Chloride channel forming receptor. One of a family of neurotransmitter receptors with fast intrinsic ion channels.
See: amino acid receptors.
(18 Nov 1997)
glycine reductase <enzyme> Glycine is reductively deaminated to acetate and ammonia by a complex requiring a dithiol and synthesizing ATP
Registry number: EC 1.4.1.-
(26 Jun 1999)
glycine-rich beta-glycoprotein <enzyme> A glycine-rich, heat-labile beta-glycoprotein found in blood. It is a proactivator of complement 3 in the alternate pathway of complement activation. Factor b is converted by factor d to c3 convertase.
Registry number: EC 3.4.21.47
(12 Dec 1998)
glycine-rich beta-glycoproteinase <enzyme> A serum protein which during the alternate pathway of complement activation converts the inactive properdin factor b to c3 convertase.
Registry number: EC 3.4.21.46
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • glycine
    ±Û¸®½Å(¾Æ¹Ì³ë»êÀÇ Çϳª)
  • cleavage
    ºÐ¿­
  • class cleavage
    À¯ºÐ¿­(ÇÑ ³¹¸»À» µÑ ÀÌ»óÀÇ Çü½Ä·ù·Î ¾²´Â °Í)
  • cleavage
    Âɰ³Áü;¿­°³;ºÐÇÒ;(Á¤´ç µîÀÇ)ºÐ¿­;º®°³;º®°³¸é;ºÐ¿­;(¼öÁ¤¶õÀÇ)³­ÇÒ;( ¸ñ ºÎºÐÀÌ ±íÀº µå·¹½º¿¡¼­ µå·¯³ª º¸ÀÌ´Â)À¯¹æ »çÀÌÀÇ °ñÂ¥±â
  • system
    Á¶Á÷,°èÅë,¹æ½Ä
  • Bertillon system
    º£¸£Æ¼¿ë½Ä ¹üÀνĺ°¹ý(Áö¹®À» Áß½Ã)
  • CAPTAIN System
    ĸƾ½Ã½ºÅÛ(°¡Á¤ÀÇ À¯¼± ÅÚ·¹ºñÀü¿¡ÀÇ Á¤º¸ Á¦°ø ½Ã½ºÃÀ,»óÇ¥¸í)
  • Continental System
    ´ë·úºÀ¼â(1806³â NapoleonÀÇ ¿µ±¹¿¡ ´ëÇÑ)
  • Copernican system
    ÄÚÆä¸£´ÏÄí½º¼³(ü°è);(žçÁ߽ɼ³,Áöµ¿¼³)
  • Dewey classification system
    µµ¼­ÀÇ µàÀÌ 10Áø ºÐ·ù¹ý
  • Dolby system
    µ¹ºñ¹æ½Ä(³ìÀ½ Å×ÀÌÇÁÀÇ ÀâÀ½À» ÁÙÀÌ´Â ¹æ¹ý)
  • Doppler Lidar System
    µµÇ÷¯ È¿°ú¸¦ ÀÌ¿ëÇÑ ±¤ÇÐ½Ä ¼Óµµ°è
  • European Monetary System
    À¯·´ ÅëÈ­ Á¦µµ
  • Federal Reserve System
    ¿¬¹æÁغñÁ¦µµ
  • Gary system
    °Ô¸®½Ä Çб³ Á¦µµ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á